Physician profile
Doan Vu
NPI 1023126349
$980.43
in general payments reported to CMS, 2019-2025
10 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2023: $79.62 · 2024: $597 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $334.39 | 2024 | |
| Inari Medical, INC. | $281.50 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $116.79 | 2019 | |
| Imperative Care, INC | $77.14 | 2025 | Symphony Catheter |
| Stryker Corporation | $50.55 | 2025 | Inthrill Thrombectomy Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ge Healthcare | $33.06 | 2024 | |
| Cardiva Medical, INC. | $27.52 | 2023 | Cardiva Vascade 6/7f Vcs |
| Boston Scientific Corporation | $22.54 | 2019 | |
| Terumo Medical Corporation | $19.48 | 2019 | |
| Cook Medical LLC | $17.46 | 2025 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doan Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.